Surgical Oncology in Turkey

Surgical oncology in Turkey gives international patients access to accredited (often JCI-accredited) cancer centres, experienced surgeons and modern theatres at a fraction of UK or US costs, with planning driven by a multidisciplinary tumour board rather than a single opinion. Unal Cakar is an independent facilitator and patient advocate: he arranges a written second-opinion review, vetted hospital selection, treatment coordination and structured aftercare. He does not perform surgery and is not a clinic, and you only ever pay the hospital directly.

Surgical oncology is the branch of surgery dedicated to diagnosing, staging and removing cancer. It covers a wide range of operations across the breast, digestive tract, lung, thyroid, gynaecological organs, skin (melanoma), soft tissue, urological organs and more. The surgeon's goal is usually to remove the tumour together with a clear margin of healthy tissue, and where appropriate to remove or sample the nearby lymph nodes that drain the area, so the disease can be accurately staged.

In modern practice, surgery is rarely a stand-alone decision. It sits within a treatment plan agreed by a multidisciplinary team (MDT) or 'tumour board' that may include a surgical oncologist, medical oncologist, radiation oncologist, radiologist and pathologist. Depending on the cancer type and stage, surgery may be combined with chemotherapy, radiotherapy, hormonal or targeted therapy given before (neoadjuvant) or after (adjuvant) the operation.

The pathway begins with accurate staging: imaging (CT, MRI, PET-CT, ultrasound) and a tissue diagnosis from a biopsy are reviewed so the team understands exactly what is being treated. The case is then discussed by the tumour board, which recommends whether surgery is appropriate, what type, and in what sequence relative to any chemotherapy or radiotherapy. This is the single most important step and is where an independent second opinion can genuinely change a plan.

The operation itself may be open, laparoscopic (keyhole) or robotic-assisted, depending on the tumour and the surgeon's assessment. Many cancer operations now use tissue-sparing and minimally invasive approaches where oncologically safe, along with techniques such as sentinel lymph node biopsy to avoid removing more nodes than necessary. Every specimen is sent for detailed pathology, and the final histology report — margins, node status, biological markers — guides whether any further (adjuvant) treatment is advised.

• Every case planned by a multidisciplinary tumour board, not a single surgeon
• Independent written second opinion arranged before any commitment
• Accredited (often JCI-accredited) hospitals with on-site pathology and intensive care backup
• Minimally invasive and robotic-assisted techniques used where oncologically appropriate
• Translated medical summary and documented handover to your home oncology team

1. 01

   Remote review and second opinion

   You send your imaging, biopsy and pathology reports. A vetted oncology team reviews them and provides a written second opinion on whether surgery is appropriate and how it fits the overall plan.

2. 02

   Tumour board planning

   Your case is discussed by a multidisciplinary team so the recommended approach reflects several specialists, not one surgeon. You receive a clear plan, the proposed procedure and an itemised hospital quote before you travel.

3. 03

   Pre-operative assessment and staging

   On arrival, any additional scans, blood tests and anaesthetic checks are completed to confirm staging and fitness for surgery. The final plan is confirmed with you in your own language.

4. 04

   Surgery and inpatient recovery

   The operation is carried out by the surgical oncology team, followed by an inpatient stay whose length depends entirely on the procedure. Pain control, mobilisation and wound care are managed on the ward.

5. 05

   Pathology and adjuvant planning

   The removed tissue is analysed in detail. The histology result is explained to you, and the tumour board advises whether chemotherapy, radiotherapy or further follow-up is recommended.

6. 06

   Coordinated aftercare and handover

   Unal coordinates discharge instructions, a translated medical summary and a handover so your oncologist or GP at home can continue surveillance and any ongoing treatment seamlessly.

Suitability for cancer surgery is decided strictly on medical grounds, by the tumour board and the operating surgeon, after reviewing your imaging and pathology. Good candidates are generally patients with a confirmed or strongly suspected cancer that is potentially resectable, who are fit enough for anaesthesia and an operation, and who can attend a pre-operative assessment in person. Surgery is not always the first or best step: for some cancers, chemotherapy or radiotherapy is needed first, and for advanced or widely spread disease the goal may be systemic treatment or symptom control rather than removal. Patients with significant heart, lung or other medical conditions need careful assessment, and some cases are better treated closer to home where urgent, continuous care is available. An honest review — including the option that travelling for surgery is not advisable — is part of the process.

• Multidisciplinary tumour board planning, so the recommendation reflects several cancer specialists rather than a single surgeon
• Independent written second opinion before any commitment, which can confirm, refine or change the proposed plan
• Accredited hospitals (frequently JCI-accredited) with modern theatres, intensive care backup and detailed on-site pathology
• Access to minimally invasive and robotic-assisted techniques where they are oncologically appropriate
• Substantial cost savings versus the UK, US and much of Western Europe, with a transparent itemised quote paid directly to the hospital
• English-speaking coordination, interpreters and a translated medical summary for continuity of care at home

Recovery after cancer surgery varies enormously and is always discussed with you individually before the operation, because it depends on the procedure, the organ involved and your general health. A small skin or thyroid operation may need only a short inpatient stay and a few weeks of healing, whereas major abdominal or chest surgery can involve several days in hospital, sometimes an intensive care step-down, and a recovery measured in weeks to a couple of months. Early mobilisation, breathing exercises, pain control and wound care all begin in hospital.

Most patients are advised to plan an inpatient stay plus a period of local recovery before flying, since long-haul travel too soon after major surgery increases the risk of clots and wound problems. Unal helps arrange suitable accommodation, follow-up visits, suture or drain removal where needed, and a clear discharge plan. The histology results are typically ready within one to two weeks, and a remote review can be arranged so you understand the findings and any recommended next steps once you are home.

The aim of cancer surgery is complete removal of the tumour with clear margins and accurate staging, which gives you and your oncologist the information needed to plan any further treatment. What 'success' looks like depends on the cancer type, stage and biology, and no responsible team can promise a cure or guarantee an outcome. The final pathology report — margin status, lymph node involvement and tumour markers — is the true measure of what the operation achieved and shapes the next phase of care. Long-term results depend on ongoing surveillance and, where advised, adjuvant chemotherapy, radiotherapy or targeted therapy, which is why a clear handover to your home oncology team matters as much as the surgery itself.

Turkey has become a major destination for surgical oncology because accredited hospitals combine experienced cancer surgeons, modern operating theatres and on-site pathology with costs that are typically a fraction of UK, US or Gulf private prices — without the long public waiting lists. Unal Cakar works as an independent facilitator and patient advocate, not a clinic: he is sponsored by vetted partner hospitals, so his coordination, second-opinion arrangement and aftercare support come at no extra cost to you, and you pay the hospital directly with an itemised quote. For oncology specifically, his role is to make sure your case is genuinely reviewed by a multidisciplinary team, that you understand the plan and its risks, and that your care is handed back cleanly to your oncologist at home.